2026 Oncology Drug Development Planning Realities

Read article

2026 Oncology Drug Development Planning Realities

As we kickoff 2026, here are the operational…
Read Article

What BIO Europe 2025 Revealed About the Future of Phase I and II Oncology Trials

At BIO Europe 2025, we spoke with oncology…
Read Article

BIO Europe 2025 in Vienna

Medelis, a specialty oncology CRO focused on early-phase…
Read Article

BIO 2025 Boston: Key Takeaways for Clinical Development Teams

After four intensive days in Boston, it's clear…
Read Article

ASCO 2025 — Let’s Talk About What’s Next in Oncology

Medelis will be attending ASCO 2025 in Chicago…
Read Article

How AI is Transforming New Drug Discovery

Traditional drug discovery is immensely difficult. New drug…
Read Article

Preparing for Your Targeted Treatment in the Clinic

For the VP of Clinical Operations (or a…
Read Article

ASCO 2024 – Takeaways from Five Key Studies

If you didn’t get to attend the 2024…
Read Article

Harnessing the Power of Innovation and Collaboration: Key Takeaways ASCO 2024

The 2024 ASCO Annual Meeting presents an unmissable…
Read Article